Prepulse inhibition (PPI) is a measure of sensorimotor gating or information processing. Few studies have examined PPI in bipolar disorder (BD) ; two studies reported a PPI disruption and two reported no change. There are gender differences in PPI and within the clinical profile of BD, which may explain some of these discrepancies. Thus, the effect of gender on PPI in BD was the focus of the current study. Euthymic BD patients (14 male/15 female) were compared to age-and IQ-matched healthy control participants (16 male/16 female). Assessment of PPI included 21 pulse-alone trials (115 dB) and a total of 42 prepulsepulse trials (seven of each prepulse : 74, 78, 86 dB) at two stimulus onset asynchrony levels (SOA : 60, 120 ms). There was a grouprSOA and a grouprgender interaction, reflecting that men with BD showed reduced PPI compared to control males at the 60-ms SOA (3 % in BD vs. 26 % in controls), but not the 120-ms SOA. In contrast, women with BD had significantly increased PPI compared to female controls at the 120-ms SOA (49 % in BD vs. 29 % in controls), but not the 60-ms SOA. Compared to control participants BD patients showed changes in PPI, which are gender-dependent ; male BD participants had reduced PPI, whereas female BD participants had increased PPI. This gender difference highlights the need to consider men and women with BD as two distinct groups, at least in PPI studies.
Introduction
Bipolar disorder (BD) is a serious mental illness where patients may experience both manic episodes and syndromal major depression. BD can be characterized by an abrupt onset and a fluctuating course in which the patient returns to a relatively normal state between episodes (Berns & Nemeroff, 2003) . Gender differences are present in the clinical profile of BD, e.g. men have an earlier onset of BD, as determined by the first manic episode (Kennedy et al. 2005) . Compared to men, women have higher incidence rates throughout adulthood rather than early life and are at a greater risk for depressive episodes, episodes of mixed mania and rapid-cycling (Curtis, 2005 ; Kennedy et al. 2005 ; Leibenluft, 1996) . These gender differences may be attributed to the effect of the female sex hormone, oestrogen, in the brain. Oestrogen has been implicated in mood, higher cognitive function and sensorimotor gating (Bethea et al. 1998 ; Gogos et al. 2006 ; McEwen, 2001 ; Rubinow et al. 1998) .
Prepulse inhibition (PPI) is a measure of sensorimotor gating or in other words, information processing. Sensorimotor gating is a normal protective mechanism in the brain that filters irrelevant sensory, motor or cognitive information, allowing for coherent thought . Deficits in gating sensorimotor information may result in an information overload or a misinterpretation of stimuli and may also cause certain symptoms of schizophrenia, such as thought disorder Perry & Braff, 1994) .
In humans, PPI of the acoustic startle is measured via the eye-blink startle response . There is an extensive literature on how PPI is affected in schizophrenia patients (for review see Braff et al. 2001) . PPI is also deficient in other disorders including obsessive-compulsive disorder (Hoenig et al. 2005 ) and Huntington's disease (Swerdlow et al. 1995) . These disorders have a common underlying deficit, i.e. PPI deficits are the result of abnormalities within a specific brain circuit rather than a specific psychopathology .
A limited number of studies have recently examined PPI in BD and found that remitted or acutely manic BD patients, as well as their unaffected siblings, show disruptions of PPI compared to healthy control subjects (Giakoumaki et al. 2007 ; Perry et al. 2001) . However, other studies have shown no disruption of PPI in BD adults (Barrett et al. 2005 ; Carroll et al. 2007 ) and children (Rich et al. 2005) . These inconsistent findings do not appear to be due to current symptom severity, as two studies tested euthymic participants (Barrett et al. 2005 ; Giakoumaki et al. 2007 ) and two studies tested symptomatic participants [acute mania and psychosis (Perry et al. 2001) , manic or mixed episode (Carroll et al. 2007) ]. It is possible that a history of psychotic episodes may explain PPI deficits in BD, as psychosis can occur in BD and schizophrenia. Alternatively, gender may play a role in mediating PPI deficits.
Gender differences in PPI have been described in healthy participants, where men show greater PPI than women (Swerdlow et al. 1993) . Further, women have greater PPI during the early follicular (low oestrogen) phase of the menstrual cycle, compared to the luteal phase (Jovanovic et al. 2004 ; Swerdlow et al. 1997) . The previous PPI literature for BD does not state which stage of the menstrual cycle the women were in when tested for PPI. In the schizophrenia literature some studies have reported PPI gender differences, with disruptions in male, but not female, clinical participants (Kumari et al. 2004) , alternatively disruptions in female schizophrenia patients (Braff et al. 2005) and lastly female patients have a greater PPI disruption compared to male patients (Swerdlow et al. 2006a) , overall suggesting variable findings.
The present study aimed to examine gender differences in PPI in BD. We tested PPI in men and women with BD compared to gender-, age-and IQ-matched healthy controls. We recruited euthymic BD patients to reduce the potential confounds present when testing acutely unwell patients. Additionally, this recruitment strategy enabled us to obtain patient groups that were matched for symptom severity, a potential cause of a gender difference. We hypothesized that there would be a gender difference in PPI when comparing BD patients and controls.
Methods

Participants
The present study tested 66 participants : 31 BD patients and 35 healthy controls. All participants were aged between 21 and 61 yr, were fluent in English, and were recruited from the local community via advertisements, outpatient facilities (Northern Hospital and St Vincent's Health) and word-of-mouth. The procedures described in this study were approved by the Mental Health Research and Ethics Committee (Melbourne Health, Victoria, Australia) and participants gave their written, informed consent prior to testing.
Participants from either group were excluded if they reported a history of brain trauma, neurological illness (n=1), concurrent substance abuse (n=1), comorbidity with Axis I disorders, had undergone electroconvulsive therapy in the previous year, or had an estimated full-scale verbal IQ<80 (n=1) as indicated by the National Adult Reading Test (NART ; Nelson, 1982) . Handedness was assessed with the Edinburgh Handedness Inventory (Oldfield, 1971) . Control participants were free from psychiatric illness [selfreported and screened for current symptoms using the Brief Psychiatric Rating Scale (BPRS ; Ventura et al. 1993) ] and were excluded if they had a first-degree relative with schizophrenia or BD (n=1). Finally, one male control showed inadequate startle responses (defined in the PPI section below) and was excluded from the final analysis. Therefore, the final analysis included 61 participants (14 male/15 female BD participants, 16 male/16 female controls) ( Table 1) .
BD patients were remitted outpatients, selfreported euthymic and most were on medication. BD diagnosis was confirmed according to DSM-IV criteria during a clinical interview with a trained researcher (independent and naive to the study hypothesis) using the combined Structured Clinical Interview for DSM-IV and Positive and Negative Syndrome Scale (PANSS ; Table 1) (First et al. 1997) . As assessed using the Bech-Rafaelsen Mania Rating Scale (MRS ; Bech et al. 1979) , 27 patients were currently euthymic (score 0-10) and two patients had mild mania (score 11-15). As assessed using the Hamilton Depression Rating Scale (HAMD ; Hamilton, 1960) , 18 patients were currently euthymic (score 0-7), eight patients had mild depression (score 8-13), two patients had moderate depression (score 14-18) and one female patient had very severe depression (o23, scored 25). Of the 29 BD patients included in the study, three were unmedicated and 26 were prescribed psychotropic medication [median number of medications 2 (S.D.=0.9) ; Table 2 ].
Study design
All participants were tested once, with females tested during low levels of circulating oestrogen and progesterone in order to eliminate the confounding variable of cycling hormone levels. Therefore, women with a natural menstrual cycle were tested during the early follicular phase (days 1-8 of cycle ; n=9 BD, n=10 control), women prescribed the oral contraceptive pill were tested during administration of the inactive pills (n=2 BD, n=2 control), and postmenopausal women (lack of period for >2 years) were tested at any time (n=4 BD, n=4 control). Although all women were tested during low levels of circulating hormones, it is unclear whether the varying hormonal conditions (natural cycle vs. contraceptive pill vs. postmenopause) may be associated with endocrine effects on PPI. However, there was a similar distribution of control and BD women in each of the three hormonal conditions.
Measures
PPI involved measuring the eye-blink component of the acoustic startle response using the EMG Startle System (San Diego Instruments, USA), which was regularly calibrated (Quest SoundPro dB Meter, Quest Technologies, USA). Electromyogram (EMG) activity of the orbicularis oculi was recorded using two small Ag/AgCl electrodes (electrolyte gel-filled) placed under the right eye ; the reference electrode was attached to the right mastoid (average impedance <16 kV). The EMG system delivered acoustic stimuli binaurally to the participant via headphones (Maico, San Diego Instruments). Before being tested for PPI, all participants refrained from smoking for >20 min and underwent a hearing test indicating that they could hear o40 dB. EMG activity was amplified (full scale 0.25), band-pass filtered (10-1000 Hz) and recorded for 250 ms following stimulus onset (sample interval 1 ms). The startle amplitude output was in mV, where 1 mV=0.1 mV at the electrode. The PPI task took 20 min to complete, during which time participants were seated comfortably, instructed to minimize movement, relax, ignore the sounds and keep their eyes open during the task. The task began with 3 min of 70-dB white noise (acclimation period), which continued throughout the session. The participant was then presented with 67 acoustic stimuli in a pseudo-random order at variable intervals (12-24 s, average 16.5 s). There were 21 pulse-alone trials, i.e. a startling pulse of 115 dB, presented for 40 ms. The pulse-alone trials were grouped in three blocks : (1) the first seven trials of the session, (2) seven trials 
Am, Amisulpride ; Ar, aripiprazole ; CPZ, chlorpromazine ; Ol, olanzapine ; Qu, quetiapine ; Ri, risperidone ; Zu, zuclopenthixol. Data represent dose (mg/day) of the different medications prescribed to the participants with bipolar disorder, except for the antipsychotics which are expressed in chlorpromazine equivalents (CPZeq).
interspersed with the prepulse-pulse trials, (3) the last seven trials. There were 42 prepulse-pulse trials consisting of a 20-ms prepulse of 74, 78 and 86 dB (4, 8 and 16 dB above background) followed 60 or 120 ms later by the startling pulse of 115 dB. The startling pulse and the prepulse-pulse trials involved bursts of white noise with near instantaneous rise-fall times. The mean of the seven trials per stimulus type was used in data analysis. There were also four trials where no sound was presented (control trials). All EMG recordings were screened for spontaneous eye-blink activity and trials were excluded if excessive EMG activity occurred during 20-ms post-stimulus (baseline shifted >90 mV). Nine percent of trials were excluded for control participants and 10 % of trials for BD patients. Raw EMG data were smoothed : rolling average 3, filter order 4, pass frequency 350, response criterion 2. The magnitude of the startle response was defined as the peak EMG response within 20-100 ms post-stimulus. One participant was classified as a 'non-responder ' and excluded from any further data analysis as the average startle amplitude (of the three blocks) was <50 mV when accounting for the control trials. The following measurements of the startle response were conducted : PPI (where %PPI is) :
amplitude of block 2 pulse-alone trials x amplitude of prepulse-pulse trials amplitude of block 2 pulse-alone trials r100, startle reactivity (amplitude of block 1 pulse-alone trials), startle amplitude (amplitude of blocks 1-3), habituation (decrease in the pulse-alone amplitudes across blocks 1-3).
Data analysis
Group and gender differences in terms of demographic and clinical factors were examined using Pearson's x 2 , one-way ANOVA, independent-sample t test or Mann-Whitney U test, as required using SPSS software (SPSS Inc., USA). A p value of <0.05 was considered significant, where applicable the Greenhouse-Geisser corrected p value was instead reported.
According to the Kolmogorov-Smirnov statistic, PPI data were normally distributed and therefore analysed with a repeated-measures ANOVA. For PPI data, the main effects and interactions were analysed for group (control, BD), gender (male, female), stimulus onset asynchrony (SOA ; 60 or 120 ms) and prepulse intensity (PP4, PP8, PP16). Startle data (i.e. blocks 1-3) were highly positively skewed (KolmogorovSmirnov test, p<0.01 for each block) and had a significant heterogeneity of variance (Levene's test, p<0.05). After log-transformation (Csomor et al. 2008) , startle amplitudes were normally distributed and there was homogeneity of variance. For graphical purposes the non-transformed startle data was presented. The %PPI was based on non-transformed startle data. For startle amplitude and habituation, the main effects and interactions were analysed for group, gender and block (1-3) . The between-subjects variables were gender and group, while the withinsubjects, repeated-measures variables refer to the PPI protocol (i.e. SOA, prepulse intensity, block). When the three participants with moderate to severe depression were removed, the PPI findings did not change direction, therefore they were retained in the analysis. Further, when the analysis was repeated with handedness as an additional between-subjects variable, handedness did not interact with PPI, nor did the PPI findings change when the seven left-handed participants were removed.
Using Pearson's r correlation, the relationship between average PPI scores (60 and 120 ms ; i.e. the average of the three prepulse intensities for 60 and 120 ms) and/or startle amplitude, and each demographic and clinical variable, was examined across the four groups individually. These variables included BPRS, age, predicted IQ, age of onset, illness duration, PANSS (total and subscales), MRS and HAMD. Due to the large number of comparisons, the Bonferroni correction was applied, therefore p<0.002 was considered significant. Correlations with medication and PPI were only completed with the BD participants that were actively taking the medication of interest (Table 2 ). Pearson's r correlations were performed on the mean dosage of chlorpromazine equivalents (CPZeq), sodium valproate and lithium, and Spearman's rho correlations were performed on the medication frequencies for antipsychotics, antidepressants, sodium valproate and lithium. Similarly to Barrett et al. (2005) , we performed exploratory comparisons between patients being prescribed a certain medication or not, and whether this changed PPI levels. Based on previous literature suggesting that smoking can influence PPI (Della Casa et al. 1998 ; Postma et al. 2006) , the effect of smoking status on PPI was examined using Spearman's rho correlation and also by using smoking status as a covariate. (Tables 1 and 2) Using one-way ANOVA, the four groups were not significantly different in terms of age and predicted full-scale IQ. There was a difference in the number of smokers between the four groups [x 2 (3)=12.6, p<0.01], which was significant when comparing male BD and control participants [x 2 (1)=9.3, p<0.01], but not female participants. Forty-six percent of male and 21 % of female BD participants and 6 % of female and 0 % of male control participants were smokers. The BPRS scores of the male and female control participants were not significantly different.
Results
Demographic variables
There were no significant gender differences in BD patients in terms of illness duration, positive, negative, general or total PANSS, MRS, HAMD, or mean dose of medication (antipsychotic, sodium valproate, lithium). There was a difference in medication frequency with more male patients prescribed antipsychotics [x 2 (1)= 4.2, p=0.04], but not for lithium, sodium valproate or antidepressants. There was a significant difference in terms of age of illness onset (U 14,14 =x2.1, p=0.04), reflecting an earlier onset in women with BD (Table 1) .
PPI
The 2 groupr2 genderr2 SOAr3 prepulse intensity ANOVA revealed no main effect of group or gender. There was a significant main effect of SOA (F 1,57 =71.4, p<0.001) and prepulse intensity (F 2,114 =88.0, p< 0.001), reflecting the expected increase in PPI (i.e. greater reduction in startle) with increasing prepulse intensity and increasing SOA (Fig. 1) . There was an SOArprepulse intensity interaction (F 2,114 =7.6, p< 0.01), reflecting the increase in PPI, particularly at the lower prepulse intensities, with increasing SOA. There was an SOArprepulse intensityrgender interaction (F 2,114 =5.3, p<0.01). Importantly, there was a significant grouprSOA interaction (F 1,57 =8.8, p<0.01) and a grouprgender interaction (F 1,57 =7.5, p<0.01), suggesting that the groups exhibit different PPI depending on the SOA or gender, respectively.
In exploring the grouprgender interaction, a 2 groupr2 SOAr3 prepulse intensity ANOVA for male participants demonstrated a trend for a group effect (F 1,28 =3.7, p=0.06) and grouprSOA interaction (F 1,28 =3.4, p=0.08), reflecting the tendency for BD participants to have reduced PPI at the 60-ms SOA. The ANOVA for female participants revealed a significant grouprSOA interaction (F 1,29 =5.8, p=0.02) and a trend for a group effect (F 1,29 =3.9, p=0.06), reflecting the increased PPI in BD participants at the 120-ms SOA. Further, when comparing gender within a group, there was a trend for a gender effect for controls (F 1,30 =3.8, p=0.06) and BD (F 1,27 =3.6, p=0.07), reflecting that female controls tended to have reduced PPI compared to male controls, but male BD participants tended to have reduced PPI compared to female BD participants, respectively (Fig. 2) .
In exploring the grouprSOA interaction, a 2 groupr2 genderr3 prepulse intensity ANOVA at the 60-ms SOA demonstrated significant interactions of grouprgender (F 1,57 =4.7, p=0.03) and prepulse intensityrgender (F 2,114 =4.1, p=0.03). Examination of the data (Fig. 2) suggests that male BD participants had reduced PPI compared to male controls, while female control and BD participants showed similar PPI. This observation was confirmed using post-hoc oneway ANOVAs (male BD vs. male controls : F 1,28 =6.4, Average %PPI is the average of the three levels of prepulse intensity, and is shown at two stimulus onset asynchrony (SOA) levels (60 and 120 ms) (* p<0.05 compared to controls).
p=0.02 ; female BD vs. female controls : p=0.7). ANOVA for the 120-ms SOA also demonstrated a significant grouprgender interaction (F 1,57 =6.7, p= 0.01). One-way ANOVA comparing male control and BD participants revealed no significant main effect of group (p=0.4). In contrast, when comparing female participants, BD participants showed significantly greater PPI than controls (F 1,29 =11.4, p<0.01).
Startle amplitude
Startle reactivity (Fig. 3) , as measured by the magnitude of block 1 pulse-alone trials, was different across the groups depending on gender (grouprgender interaction : F 1,57 =4.3, p=0.04). When comparing male participants, there was a significant group effect (F 1,28 =8.0, p<0.01), reflecting the reduced startle reactivity in men with BD compared to controls ; there was no significant difference when comparing female participants. When analysing all three blocks of startle amplitude data, there was a significant main effect of block (F 2,114 =109.2, p<0.001), reflecting the reduction in startle amplitude after repeated administration of the startling pulse (i.e. habituation ; Fig. 3 ). There was no blockrgroup interaction, reflecting the similar habituation across groups. There was a grouprgender interaction (F 1,57 =4.5, p=0.04) and a trend for a group effect (F 1,57 =3.1, p=0.08). Of interest, when examining block 2 (i.e. the startle pulses used to calculate PPI) there was a grouprgender interaction (F 1,57 =5.6, p=0.02), reflecting the reduced startle amplitude in men with BD compared to male controls (F 1,28 =9.8, p<0.01).
Given that the significant difference in startle amplitude between male BD patients and controls may have influenced PPI, we repeated the analysis on a sample of participants with matched startle amplitude : male BD patients (n=9, mean=781, S.E.M.=121) and male controls (n=9, mean=778, S.E.M.=99). PPI analysis revealed a significant main effect of group (F 1,16 =5.4, p=0.03), which remained significant at the 60-ms SOA (F 1,16 =5.9, p=0.03), but not at 120 ms.
Clinical and demographic correlates
There was a trend for a positive correlation between average PPI at the 60-ms and the 120-ms SOA in male (r=0.69, p=0.003) and female controls (r=0.62, p= 0.01), but not in BD. There was no correlation between average PPI and startle data (either average startle, block 2 original or log-transformed) in any of the four groups, or between average startle and any demographic or clinical variable. In all participants there were no significant correlations between PPI (at either SOA) and demographic variables. In male BD participants there was a trend for a correlation between 60-ms average PPI and age of onset (r=0.67, p=0.009). Importantly, there were no significant correlations between PPI and symptoms (PANSS, HAMD, MRS) or any medication (dosages : CPZeq, sodium valproate, lithium ; frequencies : antipsychotics, sodium valproate, lithium, antidepressants). When all BD patients were combined, there was no difference in the effect of each medication on PPI, for either medication type.
To examine the effects of smoking on PPI, smoking status was added as a covariate to the PPI analyses. There was no significant effect of smoking, nor did it change the direction of our findings. The analyses were repeated comparing men and women in both groups for non-smokers only and the findings were similar to the whole-group results. Using Spearman's rho correlation, we found that in female BD participants there was a negative correlation between 60-ms average PPI and cigarette smoking (r=x0.58, p= 0.03) ; however, this does not explain the PPI effect that was observed in these participants at the 120-ms SOA. healthy control males (Con M, n=16) and females (Con F, n=16), and bipolar disorder (BD) males (BD M, n=14) and females (BD F, n=15). Startle reactivity refers to the startle response to the first block of seven 115 dB pulse-alone trials (top panel). Startle habituation refers to the decrease in the startle response to the pulse-alone trials across blocks 1, 2 and 3.
Discussion
The present study examined gender differences in PPI in BD. The main finding was that men and women with BD both show changes in PPI compared to healthy controls ; however, in the opposite direction. Specifically, compared to controls, men with BD showed reduced PPI, while women with BD had increased PPI. Our finding of disrupted PPI in men with BD was consistent with previous literature showing a PPI disruption in BD (Giakoumaki et al. 2007 ; Perry et al. 2001) . In both of these previous studies, the PPI disruption was greater at the 60-ms than the 120-ms SOA, similar to the present results. The present finding also parallels that of patients with schizophrenia, where men with schizophrenia have reduced PPI compared to male controls Kumari et al. 2004) . A PPI disruption has been suggested to be related to some symptoms of mental illness, such as psychosis, mania or thought disturbance (Perry & Braff, 1994 ; Perry et al. 2001) . However, in the present study and the Giakoumaki et al. (2007) study, PPI was not correlated with psychopathology, although this was not surprising as we recruited patients with low levels of psychopathology. Not all the previous literature supports the present findings ; Carroll et al. (2007) and Barrett et al. (2005) found that there was no change in PPI in BD compared to controls. This may be explained by a number of methodological and sample differences. For example, the Carroll et al. (2007) study used a low-intensity startling pulse (95 dB) and a long duration prepulse (50 ms) which may have caused a floor effect in their study ; they also tested symptomatic patients. The Barrett et al. (2005) study measured PPI using the left eye, while the majority of PPI research tests the right eye. Recently, it has been reported that PPI can be affected by startle magnitude, with a reduction in startle amplitude resulting in an increase in PPI (Csomor et al. 2008) . However, this does not appear to be a confounding factor in the present study as male BD patients showed reduced startle amplitude and reduced PPI. Further, when male participants were matched for startle, there was still a significant disruption of PPI in male BD patients compared to male controls. Strikingly, the opposite effect was observed for female participants, where women with BD showed increased PPI compared to female controls. This finding was not supported by the previous PPI literature in BD, where the majority of participants have been men (Perry et al. 2001) or there was an equal mix of men and women (Barrett et al. 2005 ; Carroll et al. 2007 ; Giakoumaki et al. 2007) . It is possible that in some studies the decrease in PPI in men with BD may have predominated, while in the other studies an increase in PPI in women was counterbalanced by a decrease in PPI in men with the net effect being no change in PPI. However, the Giakoumaki et al. (2007) study used gender as a factor in their statistical analyses, but found no significant effects of gender. The previous studies of PPI in BD did not report the stage of the menstrual cycle the women were in when tested for PPI. Given that PPI can vary in women across the menstrual cycle (Jovanovic et al. 2004 ; Swerdlow et al. 1997) , testing women at various stages may also lead to a net effect of no change in PPI. In the present study, both women with BD and control women were tested at a stage with low circulating oestrogen and progesterone. Kumari et al. (2004) speculated that the gender difference observed in their PPI study of schizophrenia patients may have been because the women were less symptomatic than the men. In the present study, there was no difference between the men and women on any of the symptom ratings. However, it is possible, that a difference in the frequency or history of psychotic episodes may influence PPI. The two studies showing a disruption of PPI in BD tested 100 % acutely psychotic patients (Perry et al. 2001) or 50 % of patients with a history of psychotic symptoms (Giakoumaki et al. 2007) . In contrast, the two studies showing no change in PPI in BD were Carroll et al. (2007) , who found no relationship between psychosis and PPI, and Barrett et al. (2005) , who did not report on psychotic features. The present study found no correlation between the Positive PANSS subscale and PPI in BD patients. Future studies should, however, specifically examine the presence of psychotic features (past and present) and their influence on PPI.
As was also speculated by Kumari et al. (2004) , a simple explanation for the increased PPI in female BD patients was that the control women showed relatively low levels of PPI compared to other studies. However, within the present study the four groups had similar PPI levels, i.e. within a close range. Further, the increase observed in female BD patients was even greater than the male participants (average PPI at 120-ms SOA : female BD 49 %, male control 42 %, male BD 35 %), where males generally have greater PPI than females (Swerdlow et al. 1993) . Alternatively, medication may have had a greater effect in women with BD. Medication can influence PPI ; some studies, but not all, have found that antipsychotics can normalize PPI in schizophrenia patients . In the present study, it is unlikely that antipsychotic medication is responsible for the PPI increase in female BD patients, as only a small number of women were prescribed an antipsychotic (5/15 patients). Further, the majority of our male BD patients were prescribed antipsychotics (10/14 patients) and they still showed a disruption of PPI. Barrett et al. (2005) suggested that BD patients prescribed sodium valproate (n=6) had reduced PPI compared to those who were not taking sodium valproate (n=17). Our results did not confirm this finding, where we had a fairly equal distribution of patients prescribed vs. not prescribed sodium valproate (Table 1 ). In our sample, most patients were on multiple and various medications (Table 2) , thus making it very difficult to extract the effect of medication on PPI. Overall, the present study found no correlation between medication and PPI. Future research in drug-naive BD patients should investigate the role of medication on PPI. Another possible limitation of the present results is that we did not match participants for smoking status, which may influence PPI (Della Casa et al. 1998 ; Postma et al. 2006) . Although there were more male smokers, further analysis revealed no significant effect of smoking status on PPI.
An increase in PPI in humans has been seen in a number of studies, e.g. after treatment with nicotine (Kumari et al. 1997) , the indirect dopamine receptor agonist, amantadine (Swerdlow et al. 2002) , the NMDA receptor antagonist, ketamine (Abel et al. 2003 ; Duncan et al. 2001 ; Heekeren et al. 2007) , the serotonin (5-HT) releaser, MDMA (Liechti et al. 2001 ; Vollenweider et al. 1999) , the 5-HT 2A receptor agonist, psilocybin (Gouzoulis-Mayfrank et al. 1998 ; Vollenweider et al. 2007 ) and by atypical antipsychotics including quetiapine (Swerdlow et al. 2006 b) and clozapine (Vollenweider et al. 2006) . Of these studies, few included female participants and only one was gender-balanced (Vollenweider et al. 2007 ). In the latter study, psilocybin treatment increased PPI at a long SOA (120 ms), but a PPI reduction occurred at a short SOA (30 ms). Thus, it is possible that the 5-HT 2A receptor may be mediating the PPI increase in BD women observed in the present study. There is some evidence for a role of 5-HT 2A receptors in BD (LopezFigueroa et al. 2004 ; Pandey et al. 2003 ; Ranade et al. 2003) . Other 5-HT receptor subtypes or other neurotransmitters may also be involved and therefore the mechanism by which a PPI increase occurred remains unknown and warrants further investigation.
In the present study, the PPI disruption in men with BD occurred only at the 60-ms SOA, while the PPI increase in women with BD occurred at the 120-ms SOA. Using different SOAs can result in different effects on PPI, with the optimal SOA (maximum inhibition) typically used in human PPI experiments being 120 ms . While PPI is generally thought of as an automatic process, at an SOA greater than 120 ms attentional influences may play a role Filion et al. 1993) . Future studies examining gender differences in BD are needed whereby attention to prepulses is controlled. Further investigation is also required in order to clarify the different roles of varying SOAs on PPI.
In conclusion, the present results showed reduced PPI in men and increased PPI in women with BD, compared to controls. Although we have proposed a number of mechanisms underlying these opposite effects on PPI, further studies are required to clarify which of these, if any, is responsible. The fact that men and women with BD showed opposite effects in PPI has implications for the interpretation of past and future BD studies. In particular, combining men and women in one group might be masking two opposite effects and this highlights the importance of acknowledging gender differences in PPI studies.
